Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

IS FECAL CALPROTECTIN AN ACCURATE MARKER IN THE MANAGEMENT OF CROHN'S DISEASE?

Vernia F, Di Ruscio M, Stefanelli G, Viscido A, Frieri G, Latella G.

J Gastroenterol Hepatol. 2019 Dec 3. doi: 10.1111/jgh.14950. [Epub ahead of print] Review.

PMID:
31795013
2.

Food Allergies and Ageing.

De Martinis M, Sirufo MM, Viscido A, Ginaldi L.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5580. doi: 10.3390/ijms20225580. Review.

3.

Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis.

Viscido A, Latella G, Frieri G.

Am J Gastroenterol. 2019 Dec;114(12):1922-1923. doi: 10.14309/ajg.0000000000000427. No abstract available.

PMID:
31658106
4.

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus.

Daperno M, Armuzzi A, Danese S, Fries W, Liguori G, Orlando A, Papi C, Principi M, Rizzello F, Viscido A, Gionchetti P.

Gastroenterol Res Pract. 2019 Sep 2;2019:3108025. doi: 10.1155/2019/3108025. eCollection 2019.

5.

Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

Pompili S, Sferra R, Gaudio E, Viscido A, Frieri G, Vetuschi A, Latella G.

Int J Mol Sci. 2019 Aug 20;20(16). pii: E4061. doi: 10.3390/ijms20164061. Review.

6.

Duodenal lymphocytosis in functional dyspepsia.

Capannolo A, Necozione S, Gabrieli D, Ciccone F, Sollima L, Melchiorri L, Viscido A, Frieri G.

Arab J Gastroenterol. 2019 Jun;20(2):91-94. doi: 10.1016/j.ajg.2019.05.006. Epub 2019 Jun 4.

PMID:
31175076
7.

[The advantages of patient's active involvement in the management of chronic Inflammatory Bowel Diseases.]

Zerboni G, Festa S, Aratari A, d'Alessio F, Viscido A, Papi C.

Recenti Prog Med. 2019 May;110(5):236-243. doi: 10.1701/3163.31446. Italian.

PMID:
31140456
8.

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Viscido A, Papi C, Latella G, Frieri G.

Biologics. 2019 Apr 9;13:23-31. doi: 10.2147/BTT.S179006. eCollection 2019.

9.

Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literature.

Manetta R, Capretti I, Belleggia N, Marsecano C, Viscido A, Bruno F, Arrigoni F, Ma L, Guglielmi G, Splendiani A, Di Cesare E, Masciocchi C, Barile A.

Acta Biomed. 2019 Apr 24;90(5-S):38-50. doi: 10.23750/abm.v90i5-S.8337.

10.

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Fiorino G, Caprioli F, Daperno M, Mocciaro F, Principi M, Viscido A, Fantini MC, Orlando A, Papi C, Annese V, Danese S, Vecchi M, Rizzello F, Armuzzi A; National patients’ association representatives; IG-IBD members.

Dig Liver Dis. 2019 May;51(5):632-639. doi: 10.1016/j.dld.2019.02.004. Epub 2019 Feb 19.

PMID:
30872085
11.

Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet.

Ciccone A, Gabrieli D, Cardinale R, Di Ruscio M, Vernia F, Stefanelli G, Necozione S, Melideo D, Viscido A, Frieri G, Latella G.

Digestion. 2019;100(4):262-268. doi: 10.1159/000495749. Epub 2018 Dec 14.

PMID:
30554200
12.

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine.

Frieri G, Galletti B, Di Ruscio M, Tittoni R, Capannolo A, Serva D, Latella G, Sollima L, Leocata P, Necozione S, Frieri R, Viscido A.

Therap Adv Gastroenterol. 2017 Oct;10(10):749-759. doi: 10.1177/1756283X17722926. Epub 2017 Aug 25.

13.

Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet.

Benedetti E, Viscido A, Castelli V, Maggiani C, d'Angelo M, Di Giacomo E, Antonosante A, Picarelli A, Frieri G.

J Cell Physiol. 2018 Jun;233(6):4383-4390. doi: 10.1002/jcp.26217. Epub 2018 Jan 4.

PMID:
29030981
14.

Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet.

Gabrieli D, Ciccone F, Capannolo A, Viscido A, Valerii G, Serva D, Necozione S, Coletti G, Calvisi G, Melideo D, Frieri G, Latella G.

United European Gastroenterol J. 2017 Oct;5(6):805-810. doi: 10.1177/2050640616684698. Epub 2017 Jan 18.

15.

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L, Annese V, Ardizzone S, Armuzzi A, Calabrese E, Caprioli F, Castiglione F, Comberlato M, Cottone M, Danese S, Daperno M, D'IncĂ  R, Frieri G, Fries W, Gionchetti P, Kohn A, Latella G, Milla M, Orlando A, Papi C, Petruzziello C, Riegler G, Rizzello F, Saibeni S, Scribano ML, Vecchi M, Vernia P, Meucci G; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis. 2017 Apr;49(4):338-358. doi: 10.1016/j.dld.2017.01.141. Epub 2017 Jan 17.

PMID:
28161290
16.

The Role on Endoscopy in Alcohol-Related Diseases.

Frieri G, Galletti B, Serva D, Viscido A.

Rev Recent Clin Trials. 2016;11(3):196-200. Review.

PMID:
27515959
17.

Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea.

Capannolo A, Viscido A, Sollima L, Marinucci A, Coletti G, Pasetti A, Frieri G, Bassotti G, Villanacci V, Latella G.

Gastroenterol Hepatol. 2017 Aug - Sep;40(7):467-470. doi: 10.1016/j.gastrohep.2016.05.005. Epub 2016 Jul 18. English, Spanish. No abstract available.

PMID:
27436817
18.

Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms.

Capannolo A, Viscido A, Barkad MA, Valerii G, Ciccone F, Melideo D, Frieri G, Latella G.

Digestion. 2015;92(1):8-13. doi: 10.1159/000430090. Epub 2015 May 30.

PMID:
26043918
19.

Nanotechnology in the treatment of inflammatory bowel diseases.

Viscido A, Capannolo A, Latella G, Caprilli R, Frieri G.

J Crohns Colitis. 2014 Sep;8(9):903-18. doi: 10.1016/j.crohns.2014.02.024. Epub 2014 Mar 28. Review.

20.

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.

Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A, Meucci G, Gasbarrini A, Guidi L, Lavagna A, Sostegni R, Onali S, Papi C, Kohn A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD).

J Crohns Colitis. 2014 Aug;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25.

PMID:
24472490

Supplemental Content

Loading ...
Support Center